RadNet (NASDAQ:RDNT) is a national provider of outpatient diagnostic imaging services operating through a network of freestanding imaging centers and clinics across the United States. The company offers a comprehensive suite of advanced imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, X-ray, mammography and nuclear medicine. In addition to its core outpatient centers, RadNet provides teleradiology services, supporting hospital and medical groups with remote interpretation by board-certified radiologists.
Founded in 1980 as one of the first companies to focus exclusively on outpatient diagnostic imaging, RadNet has grown organically and through strategic acquisitions to become one of the largest independent imaging operators in the country. Over the years, the company has expanded its footprint into key metropolitan markets, including Southern California, the New York metropolitan area, Northern California, the Mid-Atlantic region, Texas and Nevada. This geographic diversification enables RadNet to serve a wide range of patient populations and referring physicians.
RadNet’s service offerings extend beyond standard imaging procedures to include specialized clinical services such as interventional radiology, women’s imaging, and clinical trials support. Its clinical trials division partners with pharmaceutical and biotechnology companies to perform protocol-driven imaging studies in oncology, neurology and cardiovascular research. The company also invests in artificial intelligence and advanced analytics to enhance diagnostic accuracy, workflow efficiency and patient experience.
Leadership at RadNet is headed by President and Chief Executive Officer Howard Berger, who has steered the company through significant growth phases and technological advancements. Under his direction, RadNet continues to prioritize quality assurance, patient safety and collaborative relationships with healthcare providers. Through its integrated platform of outpatient centers, teleradiology services and clinical trial imaging, RadNet aims to deliver accessible, cost-effective diagnostic solutions that support better health outcomes.
